Evaluation of Effectiveness of Child-oriented Goal-setting in Paediatric Rehabilitation (the ENGAGE Approach)
NCT04096430
Autism Spectrum Disorder, Brain Damage, Chronic
Calgary, Alberta, Canada
View Trial DetailsNCT Number: NCT05907837
Cerebral palsy (CP) is the most common lifelong physical disability. It is defined as a non-progressive disorder of movement originating from neural lesions in the perinatal period, and is associated with a wide range of common comorbidities in many individuals. These include problems speaking, hearing, seeing, thinking, feeding and controlling their bladder. People with CP often have additional challenges such as behavioural and emotional issues, pain, and poor sleep. Many of these challenges respond well to intervention in early childhood, as brain plasticity is at its greatest in the first 2 years of life. However, in most clinical settings, the age for diagnosis of CP is between 24 to 29 months, after this window of neurodevelopmental opportunity.
This project will aim to improve the Early Detection of Cerebral Palsy in Ireland. This will be achieved by implementing an evidence-based approach to follow-up of High risk infants.
Interested in participating?
Request InfoUp to 40 week
All sexes
Observational
Cork University Maternity Hospital, Cork, Ireland
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 5 years
Reduce the age of diagnosis of cerebral palsy in Ireland to less than 12 months of age by using evidence based standardised motor and neurological assessments at set time points.
Time frame: 5 years
To establish a standardised approach to assessing infants at risk of CP in High Risk Follow-up Clinics across Ireland.
Contact information is provided by the study sponsor or research team.
University College Cork
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04096430
Autism Spectrum Disorder, Brain Damage, Chronic
Calgary, Alberta, Canada
View Trial DetailsNCT06111898
Brain Damage, Chronic, Brain Diseases
Geneva, Switzerland
View Trial DetailsNCT06645795
Brain Damage, Chronic, Brain Diseases
Valencia, València, Spain
View Trial DetailsNCT06134401
Brain Damage, Chronic, Brain Diseases
London, United Kingdom
View Trial Details